WallStreetZenWallStreetZen

NASDAQ: TRDA
Entrada Therapeutics Inc Stock Ownership - Who owns Entrada Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Entrada Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Mpm Bioventures 2018 LP10% Owner2026-09-0332,263$7.17
$231.33kSell
Mpm Bioventures 2014 LP10% Owner2026-09-0332,263$7.17
$231.33kSell
Dipal DoshiCEO2026-09-028,724$7.14
$62.32kSell
Mpm Bioventures 2014 LP10% Owner2026-09-0225,131$7.19
$180.69kSell
Kory James WentworthCFO2026-09-021,733$7.14
$12.38kSell
Natarajan SethuramanPres2026-09-022,079$7.14
$14.85kSell
Mpm Bioventures 2018 LP10% Owner2026-09-0225,131$7.19
$180.69kSell
Nathan J. DowdenCOO;Pres2026-09-022,528$7.14
$18.06kSell
Mpm Bioventures 2018 LP10% Owner2026-09-0129,088$7.06
$205.36kSell
Mpm Bioventures 2014 LP10% Owner2026-09-0129,088$7.06
$205.36kSell

1 of 7

TRDA insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TRDA insiders and whales buy or sell their stock.

TRDA Shareholders

What type of owners hold Entrada Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Kush Parmar23.05%8,973,386$65.51MInsider
Mpm Bioventures 2018 LP21.90%8,526,014$62.24MInsider
Mpm Bioventures 2014 LP21.90%8,526,014$62.24MInsider
5am Ventures V LP15.67%6,102,764$44.55MInsider
Baker Bros Advisors LP12.05%4,691,392$34.25MInsider
Todd Foley11.37%4,425,784$32.31MInsider
Roche Holding Ltd7.23%2,813,525$20.54MInsider
Redmile Group LLC5.02%1,954,420$14.27MInsider
Dipal Doshi1.33%517,290$3.78MInsider
Natarajan Sethuraman0.55%214,238$1.56MInsider

1 of 3

TRDA vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TRDA0.06%99.94%Net SellingNet Selling
LCTX0.05%60.39%Net Selling
ALEC0.08%43.47%Net Selling
ALXO0.08%10.66%Net BuyingNet Selling
CAMP0.07%49.92%Net BuyingNet Selling
View Top Biotech Stocks

Entrada Therapeutics Stock Ownership FAQ

Who owns Entrada Therapeutics?

Entrada Therapeutics (NASDAQ: TRDA) is owned by 0.07% institutional shareholders, 121.34% Entrada Therapeutics insiders, and 0.00% retail investors. Kush Parmar is the largest individual Entrada Therapeutics shareholder, owning 8.97M shares representing 23.05% of the company. Kush Parmar's Entrada Therapeutics shares are currently valued at $64.34M.

If you're new to stock investing, here's how to buy Entrada Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.